Background: Spinal cord injury (SCI) often involves multimodal pain control. This study aims to evaluate the efficacy and safety of cannabinoid use for the reduction of pain in SCI patients.Methods and Findings: This study followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement. We searched PubMed, EMBASE, Scopus, Cochrane, Web of Science, and ClinicalTrials.gov for relevant randomized controlled trials (RCTs) reporting the efficacy (e.g., pain relief) or safety (e.g., adverse events) of cannabinoids in patients with SCI, from inception to 25 December 2021. The study quality and the quality of evidence were evaluated by Cochrane ROB 2.0 and the Grading of Recommendations, Assessment, Development, and Evaluations system (GRADE), respectively. We used the random-effects model to perform the meta-analysis. From a total of 9,500 records, we included five RCTs with 417 SCI patients in the systematic review and meta-analysis. We judged all five of the included RCTs as being at high risk of bias. This meta-analysis indicated no significant difference in pain relief between the cannabinoids and placebo in SCI patients (mean difference of mean differences of pain scores: −5.68; 95% CI: −13.09, 1.73; p = 0.13; quality of evidence: very low), but higher odds of adverse events were found in SCI patients receiving cannabinoids (odds ratio: 3.76; 95% CI: 1.98, 7.13; p < 0.0001; quality of evidence: moderate).Conclusion: The current best evidence suggests that cannabinoids may not be beneficial for pain relief in SCI patients, but they do increase the risks of adverse events, including dizziness, somnolence, and dysgeusia, compared to the placebo. Cannabinoids should not be regularly suggested for pain reduction in SCI patients. Updating the systematic reviews and meta-analyses by integrating future RCTs is necessary to confirm these findings.
Oral cancer (OC) is one of the most common cancers worldwide, and its incidence has regional differences. In this study, the cancer registry database obtained from 1980 to 2019 was used to analyze the characteristic of incidence of OC by average annual percentage change (AAPC) and an age–period–cohort model. Spearman’s correlation was used to analyze the relationship between the age-standard incidence rates (ASR) of OC and related risk factors. Our results showed that the ASR of OC increased from 4.19 to 27.19 per 100,000 population with an AAPC of 5.1% (95% CI = 3.9–6.3, p value < 0.001) in men and from 1.16 to 2.8 per 100,000 population with an AAPC of 3.1% (95% CI = 2.6–3.6, p value < 0.001) in women between 1980–1984 and 2015–2019. The age–period–cohort model reported a trend of rising then declining for the rate ratio in men, with peaks occurring in the 1975 cohort, with a rate ratio of 6.80. The trend of incidence of oral cancer was related to changes in the consumption of cigarettes and alcohol and production of betel quid, with r values of 0.952, 0.979 and 0.963, respectively (all p values < 0.001). We strongly suggest avoiding these risk factors in order to prevent OC.
Objective This study aims to determine whether modern ultracongruent tibial inserts are associated with different outcomes in Total Knee Arthroplasty (TKA). Background Ultracongruent fixed-bearing (UCFB) and medial congruent fixed-bearing (MCFB) inserts have been known to be effective in total knee arthroplasty with patient satisfaction. Nonetheless, no supporting evidence to date exists to rank the clinical outcomes of these various congruent inserts in TKA. Methods We searched for PubMed, Embase, The Cochrane Central Register of Controlled Trials, Web of Science, and Scopus up to May 15, 2022. We selected studies involving an active comparison of UCFB or MCFB in TKAs. We performed a network meta-analysis (NMA) of randomized controlled trials (RCTs) and compared different congruent inserts. We ranked the clinical outcomes by SUCRA score with the estimate of the best treatment probability. Our primary outcomes were revision rates and radiolucent lines. Secondary outcomes were functional scores, including the range of motion (ROM), the Knee Society Score (KSS), Oxford Knee Score (OKS), and WOMAC. Results 18 RCTs with 1793 participants were obtained. The MCFB performed similar revision rates as CRFB and PSRP. CRFB and UCFB had the lowest radiolucent lines. UCFB and MCFB had the best OKS score overall. Conclusions The ranking probability for better clinical outcomes in congruent inserts demonstrated the superiority of congruent tibial inserts, including UCFB and MCFB. UCFB may be associated with improved postoperative functional outcomes. However, integrating future RCTs for high-level evidence is necessary to confirm these findings.
Objective: This study investigated Hounsfield unit (HU) differences in adult spinal deformity (ASD) surgery patients with and without proximal junctional kyphosis (PJK), a common complication. Summary Background Data: Previous studies have identified osteoporosis as a PJK risk factor, and CT scanning is a valuable tool for detecting osteoporosis through HU measurements. The study aimed to determine the level of HU difference between patients diagnosed with and without PJK. Methods: We conducted a meta-analysis using a random-effects model of randomized controlled trials and cohort studies that assessed HUs for ASD surgery patients who developed PJKs. We searched in PubMed, Embase, Ovid, The Cochrane Library, and Web of Science up to October 2022 and had two authors extract data and evaluate bias. Results: Four cohort studies with 250 patients were included in this study. Measurements of HUs at upper instrumented vertebra (UIV) and UIV+1 showed significant differences between PJKs and non-PJKs. (Mean difference (MD) at UIV: −25.36, 95% CI: −39.16, −11.56, [Formula: see text]0.0003; MD at UIV+1: −21.06, 95% CI: −38.25, −3.88, [Formula: see text]0.02). Conclusions: The study found measuring HUs of UIV and UIV+1 can predict the occurrence of PJK in ASD surgery. Further prospective studies are warranted to validate our findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.